等待开盘 08-05 09:30:00 美东时间
+12.240
+4.38%
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从46美元升至52美元;BTIG:维持Strategy"买入"评级,目标价从620美元升至700美元
08-04 09:30
Across the recent three months, 8 analysts have shared their insights on ResMed...
08-02 03:03
IDEXX Laboratories (NASDAQ:IDXX) will release its quarterly earnings report on ...
08-01 22:06
Piper Sandler analyst Adam Maeder maintains ResMed (NYSE:RMD) with a Neutral and raises the price target from $248 to $270.
08-01 20:20
ResMed (NYSE:RMD) declares $0.60/share quarterly dividend. Forward yield 0.88% Payable Sept. 18; for shareholders of record Aug. 14; ex-div Aug. 14. See RMD Dividend Scorecard, Yield Chart, & Dividend...
08-01 19:57
The latest announcement is out from Resmed ( ($RMD) ). On July 31, 2025, Resmed...
08-01 04:52
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp.
08-01 01:21
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (...
07-31 16:32
https://www.nytimes.com/2025/07/23/well/apnimed-sleep-apnea-clinical-trial-ad109.html
07-24 02:55
ResMed (NYSE:RMD) underwent analysis by 7 analysts in the last quarter, reveali...
07-16 21:02